Population: 16 million (2014 estimate)
GDP per capita (PPP) - 2013 estimate: $10,600 (2013 est)
Total expenditure on health per capita: $652 (Intl $, 2012)
- 1. Population Reference Bureau 2014, “2014 World Population Data Sheet”
- 2. World Health Organisation http://www.who.int/countries/ecu/en/ 
Ecuador lies in western South America, bordering the Pacific Ocean at the Equator, between Colombia and Peru.
Implementing Partner in-Country:
- FUVIDA - Fundación Aprendiendo a Vivir con Diabetes (Aracely Basurto and colleagues)
- FDJE - Fundacion Diabetes Juvenil Ecuador (María Paulina Mantilla and colleagues)
- Fundación Los Fresnos "Casa de la Diabetes" (Ana Fernanda Sánchez Encalada and colleagues)
International Partner: Insulin for Life
Life for a Child Support
FUVIDA: Commenced 2008
Guayaquil is the most populous city in Ecuador, and is the country’s main port. The Fundación Aprendiendo a Vivir con Diabetes (FUVIDA) provides quality care and education for an increasing number of children in and around Guayaquil whose families cannot afford care. LFAC provides donated Lilly insulin, and blood glucose monitoring for 110 children. In 2011, donated syringes/needles from Becton Dickinson were also shipped in.
FDJE: Commenced 2010
Fundacion Diabetes Juvenil Ecuador are based in Quito, Ecuador's capital, but support children and youth in Ambato, Ibarra, Loja, Cuenca, Guayaquil-Santa Elena, Portoviejo, and Galápagos. LFAC supports their work by providing insulin and strips for 24 children, in partnership with Insulin for Life, and financial assistance for health professionals to attend key international diabetes conferences such as ISPAD 2011.
Fundación Los Fresnos: Commenced 2014
Cuenca, located in the Ecuadorean highlands, is Ecuador’s third largest city and capital of the Azuay Province, an area of 8,000km² in south central Ecuador. Fundacion Los Fresnos are based here, supporting approximately 60 adolescents with type 1 diabetes, aged 11-16 years. LFAC funded the local purchase of a point of care HbA1c machine with test and control cartridges to cover all children triannually for the next 12 months. Insulin and blood glucose monitoring equipment will be provided in 2015.